The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study.
John BusbyReema KarasnehPeter MurchieÚna McMenaminShahinaz M GadallaM Constanza CamargoLisa IversenAmanda J LeeAndrew D SpenceChris R CardwellPublished in: Pharmacoepidemiology and drug safety (2019)
We found evidence of reduced gastro-oesophageal cancer risk among users of 5AR inhibitors, particularly finasteride. However, larger epidemiological studies are required before randomised controlled trials are considered.
Keyphrases